S. S. Afanasyev

S. S. Afanasyev

Auto-generated profile, based on publicly available information

S. S. Afanasyev

G. N. Gabrichevsky Research Institute for Epidemiology and Microbiology, Moscow, Russia

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 October 2016 in Bacteriophage
Verified
Journal Article
Closed access
AAAndrey V. Aleshkin
Andrey V. Aleshkin
OEO. N. Ershova
O. N. Ershova
NVN. V. Volozhantsev
N. V. Volozhantsev
ESE. A. Svetoch
E. A. Svetoch
APA. V. Popova
A. V. Popova
SBS. S. Bochkareva
S. S. Bochkareva
We have developed a phagebiotic composition using 8 virulent bacteriophages (2 strains of each species) which are able to lyse Acinetobacter baumannii, Klebsiella pneumoniae, Pseudomonas aeruginosa and Staphylococcus aureus. The unique character of the developed composition is ensured by particular properties of each bacteriophage comprising the preparation, including their range of lytic activity toward specific bacterial pathogens, morphology of their plaques, cycle of their development, restriction profile of their DNAs, specificity of their genomes (based on complete genome sequencing), and other properties. The preparation did not produce any signs of acute or chronic intoxication in the experimental animals. Therapeutic and prophylactic efficiency of the phagebiotic composition was demonstrated in the prevention and treatment of the experimental acute K. pneumoniae infection in mice. The investigations have shown that the preparation possesses a high therapeutic efficiency and is highly competitive with ciprofloxacin which is very effective against the infective strain K. pneumoniae. Our small-scale clinical trial was aimed to evaluate therapeutic effectiveness of the phagebiotic composition in an epidemiological emergency situation in an intensive care unit, caused by multi-resistant strains of Acinetobacter baumannii, Klebsiella pneumoniae and Pseudomonas aeruginosa. Seventy nine per cent of the initial samples from 14 patients’ endotracheal aspirate, blood and urine were contaminated. Twenty-four hours after the 3-day phage therapy (20 ml of cocktail at a titer for each phage 108 pfu/ml were introduced intragastrically through a tube once a day) contamination level dropped to 21%. Hence the obtained results enabled us to create a new phagebiotic composition that may be used as an alternative to antibiotics to treat these healthcare-associated infections.

4 August 2010 in Probiotics and Antimicrobial Proteins
Verified
Journal Article
Closed access
PDF file
MLM. Lakhtin
M. Lakhtin
VAV. Alyoshkin
V. Alyoshkin
VLV. Lakhtin
V. Lakhtin
SAS. Afanasyev
S. Afanasyev
LPL. Pozhalostina
L. Pozhalostina
VPV. Pospelova
V. Pospelova

19 June 2017 in Russian Journal of Infection and Immunity
Verified
Journal Article
Open access
PDF file
AПArray С. Пименова
Array С. Пименова
OBO. Yu. Borisova
O. Yu. Borisova
OTO. V. Tsvircun
O. V. Tsvircun
AБArray А. Басов
Array А. Басов
VAV. A. Aleshkin
V. A. Aleshkin
AКArray И. Кафарская
Array И. Кафарская
Purpose: whooping cough diagnostics by molecular-genetic methods.Materials and methods. Under observation there were 4930 people during the period from 2012 to 2015. All samples were received in 8 schools of Moscow and the Moscow region: in 3 schools had been found children with whooping cough, in other 5 schools – only children with prolonged cough. Whooping cough diagnosis had been given earlier by bacteriological and serological methods. 430 clinical samples were studied by 2 methods: PCR with fluorescent hybridized detection of amplified products and isothermal amplification.Results. In three of eight schools whooping cough cases at 7 children at the age of 7, 9, 11 and 15 years were revealed earlier. The diagnosis of whooping cough at them was confirmed by means of bacteriological and serological methods. 33 positive DNA samples (7.7%) are revealed. DNA-positive samples are allocated from 18 pupils and 15 employees of schools. In two schools where earlier infection sources were established, 15 DNA-positive samples from which in three cases clinical manifestations were observed are revealed. In those schools where it wasn’t earlier established a source of an infection and examinations conducted it is long the coughing children, 18 DNA-positive samples are revealed, and in two cases clinical manifestations in the form of cough were observed.Conclusion. Performed research confirmed high efectiveness of molecular-genetic methods during pertussis infection foci examination in schools for infection source identification also amongst long coughing children.

1 October 2005 in Bulletin of Experimental Biology and Medicine
Verified
Journal Article
Closed access
PDF file
ISI. G. Shemyakin
I. G. Shemyakin
APA. L. Pukhalsky
A. L. Pukhalsky
VSV. N. Stepanshina
V. N. Stepanshina
GSG. V. Shmarina
G. V. Shmarina
VAV. A. Aleshkin
V. A. Aleshkin
SAS. S. Afanas'EV
S. S. Afanas'EV

1 June 2011 in Beneficial Microbes
Verified
Journal Article
Closed access
MLM. Lakhtin
M. Lakhtin
VLV. Lakhtin
V. Lakhtin
VAV. Alyoshkin
V. Alyoshkin
SAS. Afanasyev
S. Afanasyev
In this review our last results and proposals with respect to general aspects of lectin studies are summarised and compared. System presence, organisation and functioning of lectins are proposed, and accents on beneficial symbiotic microbial lectins studies are presented. The proposed general principles of lectin functioning allows for a comparison of lectins with other carbohydrate-recognition systems. A new structure-functional superfamily of symbiotic microbial lectins is proposed and its main properties are described. The proposed superfamily allows for extended searches of the biological activities of any microbial member. Prospects of lectins of beneficial symbiotic microorganisms are discussed.

1 January 2016 in Terapevticheskii arkhiv
Verified
Journal Article
Closed access
OKO. V. Kalyuzhin
O. V. Kalyuzhin
SAS. S. Afanasyev
S. S. Afanasyev
ABA. S. Bykov
A. S. Bykov
This review analyzes whether.it is expedient to use oral probiotics for the stimulation of immune response against pathogens in the respiratory tract. It considers a relationship between.mucosal microbial colonization in different biotopes of the body and mucosal.immunity in the respiratory tract. The principal and terminological controversial issues of colonic dysbiosis and the possibilities of using the medicines and products containing live commensals/symbionts to correct microbiota disturbances are examined. There are data on the degree of resistance and resilience of the colonic microbial community exposed to destabilizing factors, antibiotics in particular. The properties of probiotics that have been proven to enhance host response against pathogens and the phenomena that characterize these probiotics as immunomodifiers and distinguish them from other immunostimulating/immunomodulating agents are described. Criteria for choosing effective and safe oral probiotics to stimulate an immune response in the respiratory tract are formulated. Finally, we review the data on the clinical and immunomodulatory effects of dietary supplement containing a combination of three probiotic strains (Lactobacillus gasseri PA 16/8, Bifidobacterium bifidum MF 20/5 and Bifidobacterium longum SP 07/3) with vitamins and minerals as an agent to prevent and reduce the severity of acute and recurrent respiratory tract infections.